4/28/2010

Hana Biosciences said it will file a rolling new-drug application with the FDA for Marqibo, its drug candidate for relapsed/refractory adult acute lymphoblastic leukemia. The announcement comes after the company concluded a pre-application meeting with the agency about the drug.

Related Summaries